LAMPALIZUMAB

UNII: UWU93Y99R3
Preferred Substance Name: LAMPALIZUMAB

1278466-20-8
AFD
ANTI-FACTOR-D
ANTI-FD
FCFD4514S
FCFD-4514S
IMMUNOGLOBULIN G1, ANTI-(HUMAN COMPLEMENT FACTOR D) (HUMAN-MOUSE MONOCLONAL FCFD4514S HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL FCFD4514S LIGHT CHAIN
LAMPALIZUMAB [INN]
LAMPALIZUMAB [USAN]
LAMPALIZUMAB [WHO-DD]
RG7417
RG-7417
SN578B8Z9Q

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

LAMPALIZUMAB

Synonyms and Mappings

Resources

Note